StockNYSECOR

Cencora

309,87 $

-2.41 (-0.77%)heute

Valuation & earnings

P/E ratio: 22.99
Forward P/E: 15.64
EPS (ttm): $13.48
Forward EPS: $19.81
Price/book: 19.38
PEG ratio: 0.65
Dividend yield: 0.77%
Payout ratio: 17.45%

Financials (ttm)

Revenue (ttm): 332.8B
Revenue growth: 5.1%
Profit margin: 0.79%
Return on equity: 96.87%
Total cash: 2.8B
Total debt: 14.5B

Earnings (EPS)

Quarter	Estimate	Actual	Surprise
Sep 30, 2025	3.79	3.84	+1.44%
Dec 31, 2025	4.04	4.08	+0.99%
Mar 31, 2026	4.72	4.75	+0.65%
Jun 30, 2026	4.35	4.48	+3.04%

Next earnings date: Nov 4, 2026

Analyst view

Consensus ratingBuy15 analysts

Strong buy 4Buy 8Hold 3

12-month price targetsImplied upside: +19.18%

330

369.31

430

LowCurrent priceHigh

Dividends

Dividend yield: 0.77%
Dividend (annual): $2.40
Ex-dividend date: Aug 14, 2026

Recent payments

Aug 14, 2026 · $0.60May 15, 2026 · $0.60Feb 13, 2026 · $0.60Nov 14, 2025 · $0.60Aug 15, 2025 · $0.55

Key stats

Previous close: $312.28
Day range: 309.18 – 316.61
52-week range: 244.82 – 377.54
Volume: 1.1M
Avg. volume: 1.4M
Market cap: 59.1B
Beta: 0.57
52-week change: 0.93%
Currency: USD

Profile

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provi(English)

Sector: Healthcare
Industry: Medical Distribution
Employees: 47,000
Headquarters: Conshohocken, United States

Visit website

Market data provided by Yahoo Finance, may be delayed. For informational purposes only — not investment advice.